# Effetivity of Dutasteride and Aloe Vera Extract Combination on Angiogenesis and Obstruction on Benign Prostatic Hyperplasia

> **NCT07065682** · PHASE1 · RECRUITING · sponsor: **Universitas Diponegoro** · enrollment: 84 (estimated)

## Conditions studied

- BPH (Benign Prostatic Hyperplasia)

## Interventions

- **DRUG:** Aloevera + dutasteride
- **DRUG:** Dutasteride (0.5mg)

## Key facts

- **NCT ID:** NCT07065682
- **Lead sponsor:** Universitas Diponegoro
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-07-01
- **Primary completion:** 2024-12-01
- **Final completion:** 2027-12-01
- **Target enrollment:** 84 (ESTIMATED)
- **Last updated:** 2025-07-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07065682

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07065682, "Effetivity of Dutasteride and Aloe Vera Extract Combination on Angiogenesis and Obstruction on Benign Prostatic Hyperplasia". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT07065682. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*